144 related articles for article (PubMed ID: 29790374)
1. Hybrid liposomes showing enhanced accumulation in tumors as theranostic agents in the orthotopic graft model mouse of colorectal cancer.
Okumura M; Ichihara H; Matsumoto Y
Drug Deliv; 2018 Nov; 25(1):1192-1199. PubMed ID: 29790374
[TBL] [Abstract][Full Text] [Related]
2. Theranostics with Hybrid Liposomes in an Orthotopic Graft Model Mice of Breast Cancer.
Ichihara H; Okumura M; Tsujimura K; Matsumoto Y
Anticancer Res; 2018 Oct; 38(10):5645-5654. PubMed ID: 30275183
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of hybrid liposomes without drugs for rheumatoid arthritis.
Matsumoto Y; Ichihara H; Hino M; Umebayashi M; Ueoka R
Drug Deliv; 2015; 22(5):619-26. PubMed ID: 24344811
[TBL] [Abstract][Full Text] [Related]
4. Intravenous injection of hybrid liposomes suppresses the liver metastases in xenograft mouse models of colorectal cancer in vivo.
Ichihara H; Hino M; Umebayashi M; Matsumoto Y; Ueoka R
Eur J Med Chem; 2012 Nov; 57():143-8. PubMed ID: 23059544
[TBL] [Abstract][Full Text] [Related]
5. Nanotherapy with hybrid liposomes for colorectal cancer along with apoptosis in vitro and in vivo.
Ichihara H; Nakagawa S; Matsuoka Y; Yoshida K; Matsumoto Y; Ueoka R
Anticancer Res; 2014 Sep; 34(9):4701-8. PubMed ID: 25202047
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Effects of Hybrid Liposomes Against Xenograft Mouse Model of Colorectal Cancer In Vivo Due to Long-term Accumulation.
Ichihara H; Okumura M; Matsumoto Y
Anticancer Res; 2016 Nov; 36(11):5875-5882. PubMed ID: 27793911
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of hybrid liposomes on the growth of liver cancer stem cells.
Inamura K; Komizu Y; Yamakuchi M; Ishida S; Matsumoto Y; Matsushita T
Biochem Biophys Res Commun; 2019 Jan; 509(1):268-274. PubMed ID: 30583860
[TBL] [Abstract][Full Text] [Related]
8. Trehalose Liposomes Suppress the Growth of Tumors on Human Lung Carcinoma-bearing Mice by Induction of Apoptosis
Ichihara H; Kuwabara K; Matsumoto Y
Anticancer Res; 2017 Nov; 37(11):6133-6139. PubMed ID: 29061794
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Combination Chemotherapy Using a Novel Oral Chemotherapeutic Agent, TAS-102, with Oxaliplatin on Human Colorectal and Gastric Cancer Xenografts.
Nukatsuka M; Nakagawa F; Takechi T
Anticancer Res; 2015 Sep; 35(9):4605-15. PubMed ID: 26254349
[TBL] [Abstract][Full Text] [Related]
10. Primary and Acquired Resistance of Colorectal Cancer to Anti-EGFR Monoclonal Antibody Can Be Overcome by Combined Treatment of Regorafenib with Cetuximab.
Napolitano S; Martini G; Rinaldi B; Martinelli E; Donniacuo M; Berrino L; Vitagliano D; Morgillo F; Barra G; De Palma R; Merolla F; Ciardiello F; Troiani T
Clin Cancer Res; 2015 Jul; 21(13):2975-83. PubMed ID: 25838391
[TBL] [Abstract][Full Text] [Related]
11. SKLB316, a novel small-molecule inhibitor of cell-cycle progression, induces G2/M phase arrest and apoptosis in vitro and inhibits tumor growth in vivo.
Xia Y; Lei Q; Zhu Y; Ye T; Wang N; Li G; Shi X; Liu Y; Shao B; Yin T; Zhao L; Wu W; Song X; Xiong Y; Wei Y; Yu L
Cancer Lett; 2014 Dec; 355(2):297-309. PubMed ID: 25301449
[TBL] [Abstract][Full Text] [Related]
12. Delivery of Rapamycin by Liposomes Synergistically Enhances the Chemotherapy Effect of 5-Fluorouracil on Colorectal Cancer.
Chen YQ; Zhu WT; Lin CY; Yuan ZW; Li ZH; Yan PK
Int J Nanomedicine; 2021; 16():269-281. PubMed ID: 33469286
[TBL] [Abstract][Full Text] [Related]
13. Bisleuconothine A, a bisindole alkaloid, inhibits colorectal cancer cell in vitro and in vivo targeting Wnt signaling.
Kong LM; Feng T; Wang YY; Li XY; Ye ZN; An T; Qing C; Luo XD; Li Y
Oncotarget; 2016 Mar; 7(9):10203-14. PubMed ID: 26862734
[TBL] [Abstract][Full Text] [Related]
14. The labdane diterpene sclareol (labd-14-ene-8, 13-diol) induces apoptosis in human tumor cell lines and suppression of tumor growth in vivo via a p53-independent mechanism of action.
Mahaira LG; Tsimplouli C; Sakellaridis N; Alevizopoulos K; Demetzos C; Han Z; Pantazis P; Dimas K
Eur J Pharmacol; 2011 Sep; 666(1-3):173-82. PubMed ID: 21620827
[TBL] [Abstract][Full Text] [Related]
15. Remarkable inhibitory effects of hybrid liposomes on growth of human colon cancer cells through induction of cell cycle arrest along with apoptosis.
Komizu Y; Ueoka H; Goto K; Ueoka R
Int J Nanomedicine; 2011; 6():1913-20. PubMed ID: 21931486
[TBL] [Abstract][Full Text] [Related]
16. Anti-proliferative effects of a new docosapentaenoic acid monoacylglyceride in colorectal carcinoma cells.
Morin C; Rousseau É; Fortin S
Prostaglandins Leukot Essent Fatty Acids; 2013 Sep; 89(4):203-13. PubMed ID: 23932824
[TBL] [Abstract][Full Text] [Related]
17. Weichang'an and 5-fluorouracil suppresses colorectal cancer in a mouse model.
Tao L; Yang JK; Gu Y; Zhou X; Zhao AG; Zheng J; Zhu YJ
World J Gastroenterol; 2015 Jan; 21(4):1125-39. PubMed ID: 25632185
[TBL] [Abstract][Full Text] [Related]
18. Anticancer bioactive peptides suppress human colorectal tumor cell growth and induce apoptosis via modulating the PARP-p53-Mcl-1 signaling pathway.
Su LY; Shi YX; Yan MR; Xi Y; Su XL
Acta Pharmacol Sin; 2015 Dec; 36(12):1514-9. PubMed ID: 26592508
[TBL] [Abstract][Full Text] [Related]
19. [Marked therapeutic effects of hybrid liposomes on the hepatic metastasis of colon carcinoma].
Funamoto K; Ichihara H; Matsushita T; Matsumoto Y; Ueoka R
Yakugaku Zasshi; 2009 Apr; 129(4):465-73. PubMed ID: 19337001
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumor effects of cationic hybrid liposomes against colon carcinoma along with apoptosis in vitro.
Hino M; Ichihara H; Matsumoto Y; Ueoka R
Biol Pharm Bull; 2012; 35(11):2097-101. PubMed ID: 23123481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
